Disc Medicine (IRON) Change in Account Payables (2020 - 2026)
Disc Medicine (IRON) posted quarterly Change in Account Payables of -$4.9 million for Q2 2026, down 1432.4% year-over-year from $369183.8 in Q2 2025, and down 279.46% quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
Disc Medicine (IRON) Change in Account Payables (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Change in Account Payables for 7 consecutive years, with -$4.9 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Account Payables fell 1432.4% year-over-year to -$4.9 million; the TTM figure through Jun 2026 stood at $490000.0 (down 72.0% YoY), while the FY2025 annual figure was $1.1 million, up 122.86% from the prior year.
- Change in Account Payables fell to -$4.9 million in Q2 2026 per IRON's latest filing, from $2.7 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.4 million in Q4 2024 and bottomed at -$10.8 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$500222.2 across 5 years, with a median of -$362000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 5463.51% — and 2026, when it tumbled 1432.4%.
- Disc Medicine's Change in Account Payables stood at -$74000.0 in 2022, then surged by 5463.51% to $4.0 million in 2023, then advanced by 10.73% to $4.4 million in 2024, then sank by 60.18% to $1.8 million in 2025, then plunged by 381.09% to -$4.9 million in 2026.
- Business Quant data shows IRON's Change in Account Payables at -$4.9 million in Q2 2026, $2.7 million in Q1 2026, and $1.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Disc Medicine | 3.06 Bn | 3.06 Bn | - | -4.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.92 Mn |
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | -321,000.00 |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | -1.05 Mn |
| Jun 30, 2024 | -669,000.00 |
| Mar 31, 2024 | -7.36 Mn |
| Dec 31, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.77 Mn |
| Jun 30, 2023 | -726,000.00 |
| Mar 31, 2023 | -10.75 Mn |
| Dec 31, 2022 | -74,000.00 |
| Sep 30, 2022 | -403,000.00 |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -982,000.00 |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | -501,000.00 |